STAT1‐associated intratumoural T H 1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer-Reference-Cited by-同舟云学术

STAT1‐associated intratumoural T H 1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer

Published:2016-09-19 Issue:4 Volume:2 Page:259-270
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Au Katrina K¹,Le Page Cécile²,Ren Runhan¹,Meunier Liliane²,Clément Isabelle²,Tyrishkin Kathrin³,Peterson Nichole⁴,Kendall‐Dupont Jennifer²,Childs Timothy³,Francis Julie‐Ann⁴,Graham Charles H¹,Craig Andrew W¹⁵,Squire Jeremy A⁶,Mes‐Masson Anne‐Marie²⁷,Koti Madhuri¹⁴⁵

Affiliation:

1. Department of Biomedical and Molecular SciencesQueen's UniversityKingston OntarioK7L 3N6 Canada

2. Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) and Institut du cancer de MontréalMontreal QuebecH2X 0A9 Canada

3. Department of Pathology and Molecular MedicineKingston General HospitalKingston OntarioK7L 3N6 Canada

4. Department of Obstetrics and GynecologyKingston General HospitalKingston OntarioK7L 3N6 Canada

5. Cancer Biology and Genetics DivisionQueen's Cancer Research Institute, Queen's University OntarioK7L 3N6 Canada

6. Departments of Genetics and Pathology Faculdade de Medicina de Ribeirão Preto ‐ USPAv. BandeirantesRibeirão Preto São Paulo3900 Brazil

7. Department of MedicineUniversité de MontréalMontreal QuebecH3C 3J7 Canada

Funder

Terry Fox Research Institute

Cancer Research Society

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.55

Reference51 articles.

1. Immunotherapy for ovarian cancer

2. Ovarian cancer

3. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

4. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

5. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer;Journal of Obstetrics and Gynaecology;2024-06-12

2. CT radiomics prediction of CXCL9 expression and survival in ovarian cancer;Journal of Ovarian Research;2023-08-30

3. PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1;Aging;2023-05-20

4. The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy;Cancers;2023-04-26

5. Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer;Cancers;2023-04-18